Testing effectiveness (Phase 2)Ended earlyNCT00506519
What this trial is testing
Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
Who this might be right for
Disseminated Intravascular Coagulation
LEO Pharma 25